DNA duplication reveals cancer drivers

DNA duplications in cancer cells act like "back-seat drivers" for the disease, according to the findings of a major British research project unveiled last night.

Scientists at the Wellcome Trust Sanger Institute, Cambridge, have been studying the role of tandem duplication.

Reporting in Nature Genetics, the researchers identify 33 locations where they have found tandem duplication, which appeared to trigger extra cancerous activity.

They say that up until now these tandem duplicates have been regarded as inactive passengers.

The findings come from a study of 560 genomes from breast cancer patients in the USA, Europe and Asia.

The researchers also studied a small number of patients with cancer of the ovaries and pancreas and found similar effects.

Researcher Dominik Glodzik said: “DNA in breast cancers is heavily restructured by many tandem duplications. We were curious whether this mutational signature influences how cancer develops.

"From our research, it now looks like some of these tandem duplications are not just unimportant passenger mutations, but actually create new driver mutations for cancer.”

Fellow researcher Professor Gerard Evans, from Cambridge University, said: “Remarkably, we also found that these acquired hotspots for tandem duplications coincide with genome regions where we find not only inherited genetic changes that increase the risk of developing breast cancer, but also controllers of genes that specify the identity of breast epithelial tissue.

"This is a first report that demonstrates a link between the acquired and the inherited genetic changes that drive breast cancers.”

Fellow researcher Dr Serena Nik Zainal said: “This is a mutational signature that should be a target for therapeutic intervention.

"Further study is needed to understand this mechanism, and for finding out whether tumours with tandem duplications at these hotspots could respond to certain treatments better than others.”

Dominik Glodzik et al. A somatic mutational process in breast cancer genomes recurrently duplicates breast cancer germline susceptibility loci and breast cancer-specific super-enhancers. Nature Genetics 23 January 2017; doi: 10.1038/ng.3771

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index